Latest Breaking News On - Vor biopharma daily - Page 2 : comparemela.com

Vor Biopharma (NYSE:VOR) Rating Reiterated by Wedbush

Wedbush reiterated their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $11.00 price target on the stock. Wedbush also issued estimates for Vor Biopharma’s Q1 2025 earnings at ($0.24) EPS, Q2 2025 earnings at ($0.24) EPS, Q3 2025 […]

United statesCharles schwab investment management incBoothbay fund managementVor biopharma incVor biopharma company profileRenaissance technologiesAmerica corpVor biopharmaFree reportFund managementSchwab investment managementGet free reportBiopharma incVor biopharma daily

JMP Securities Reaffirms Market Outperform Rating for Vor Biopharma (NYSE:VOR)

JMP Securities Reaffirms Market Outperform Rating for Vor Biopharma (NYSE:VOR)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausBoard of administration florida retirement systemVor biopharma incVor biopharma company profileAmerica corpVirtu financialVor biopharmaFree reportStreet groupFlorida retirement systemGet free reportBiopharma incVor biopharma daily

Vor Biopharma Inc (NYSE:VOR) Receives $15 19 Average PT from Analysts

Vor Biopharma Inc (NYSE:VOR) Receives $15 19 Average PT from Analysts
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United statesAmerican international group incVor biopharma incWells fargo companySg americas securitiesExchange traded conceptsTucker asset managementVor biopharmaGet free reportMarketbeat ratingsInternational groupTraded conceptsAsset managementWells fargoGet freeBiopharma inc

Vor Biopharma (NYSE:VOR) Stock Price Down 2 5%

Vor Biopharma (NYSE:VOR) Stock Price Down 2 5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesTower research capitalVor biopharma incBoard of administration florida retirement systemAmerica corpSg americas securitiesVor biopharmaGet free reportResearch capitalFlorida retirement systemBiopharma incVor biopharma daily

Vor Biopharma s (VOR) Outperform Rating Reiterated at Wedbush

Vor Biopharma (NYSE:VOR – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a report issued on Thursday, Benzinga reports. They presently have a $11.00 price objective on the stock. Wedbush’s target price suggests a potential upside of 378.26% from the company’s previous close. Vor Biopharma Trading Down 0.9 % VOR opened […]

Vor biopharma incTower research capitalVor biopharma company profileTucker asset managementSg americas securitiesExchange traded conceptsVor biopharmaGet free reportBiopharma trading downTraded conceptsResearch capitalBiopharma incVor biopharma dailyNyse vorReiterated rating